Current understanding and controversies on the clinical implications of fibroblast growth factor 21-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current understanding and controversies on the clinical implications of fibroblast growth factor 21

Published:2020-12-31 Issue:5 Volume:58 Page:311-328
ISSN:1040-8363
Container-title:Critical Reviews in Clinical Laboratory Sciences
language:en
Short-container-title:Critical Reviews in Clinical Laboratory Sciences

Author:

Badakhshi Yasaman¹²³,Jin Tianru¹²³

Affiliation:

1. Division of Advanced Diagnostics, Toronto General Hospital Research Institute, University Health Network, Toronto, Canada

2. Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, Canada

3. Banting and Best Diabetes Center, Faculty of Medicine, University of Toronto, Toronto, Canada

Funder

Canadian Institutes of Health Research

Publisher

Informa UK Limited

Subject

Biochemistry (medical),Clinical Biochemistry,General Biochemistry, Genetics and Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10408363.2020.1864278

Reference156 articles.

1. Identification of a novel FGF, FGF-21, preferentially expressed in the liver

2. FGF-21 as a novel metabolic regulator

3. Additive protection by LDR and FGF21 treatment against diabetic nephropathy in type 2 diabetes model

4. Fibroblast Growth Factor 21 Corrects Obesity in Mice

5. PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hormone based therapy and crosstalk beyond hormones;Medical Review;2024-07-25

2. The role of FGF21 in the interplay between obesity and non-alcoholic fatty liver disease: a narrative review;Romanian Journal of Morphology and Embryology;2024-07-15

3. Hepatic fibroblast growth factor 21 is required for curcumin or resveratrol in exerting their metabolic beneficial effect in male mice;2024-06-11

4. Hepatic function of glucagon-like peptide-1 and its based diabetes drugs;Medical Review;2024-06-04

5. Fibroblast growth factor 21 (FGF21): diagnostic, prognostic and therapeutic aspects in heart failure. A review;Consilium Medicum;2024-05-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3